title: Review article: the management of severe Crohn's disease.
abstract: The treatment of severe and active Crohn's disease is currently based on immunosuppression, but also involves the management of nutrition, appropriate selection of patients for surgery, and maintenance of remission in the long term. Corticosteroids remain the drug of the first choice, particularly in the acute setting. However, there is evolving understanding of the role of other immunosuppressants and immune modifiers, as major concerns regarding side-effects and efficacy of steroids in the medium to long-term drive the search for alternatives.
authors.affiliation: Gastroenterology Unit, Radcliffe Infirmary, Oxford, UK.
authors.forename: M
authors.initials: M
authors.lastname: Parkes
authors.forename: D P
authors.initials: DP
authors.lastname: Jewell
mesh_terms: D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D003424:Crohn Disease / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D010347:Patient Care Planning; D011379:Prognosis; D012720:Severity of Illness Index
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents